U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX12721053: GSM5643363: Hypoxia_DMSO_HUVEC_1 [Hyp-DMSO_1]; Homo sapiens; RNA-Seq
1 ILLUMINA (NextSeq 2000) run: 55.8M spots, 3.8G bases, 1.2Gb downloads

Submitted by: NCBI (GEO)
Study: Effects of DNA topoisomerase inhibitor acriflavine on endothelial gene expression under hypoxic conditions
show Abstracthide Abstract
RNA-Seq of human endothelial cells treated with acriflavine (ACF) with or without hypoxia revealed massive changes on gene expression. These were non-randomly and potentially due to DNA topoisomerase inhibition rather than HIF inhibition. Surprisingly, in contrast to protein-coding genes, RNA-Seq yielded that an exceeding number of lncRNAs is upregulated. Overall design: Examination of acriflavine treatment in HUVECs under hypoxia (16h, 1% O2)
Sample: Hypoxia_DMSO_HUVEC_1 [Hyp-DMSO_1]
SAMN22456150 • SRS10670459 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: NextSeq 2000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: Total RNA Isolation was performed using the RNA Mini Kit (Bio&Sell). 1µg of total RNA was used as input for SMARTer Stranded Total RNA Sample Prep Kit - HI Mammalian (Takara) using manufactures protocols.
Experiment attributes:
GEO Accession: GSM5643363
Links:
Runs: 1 run, 55.8M spots, 3.8G bases, 1.2Gb
Run# of Spots# of BasesSizePublished
SRR1651829155,839,3943.8G1.2Gb2022-01-20

ID:
17321947

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...